Back to today’s briefing

Story perspectives

Revolutionary ctDNA Testing Promises Breakthroughs in Cancer Diagnostics

4/11/2025

38 6

Summary

Story summary

At the HOPA 2025 Annual Conference in Portland, Oregon, experts Mark Zangardi and Amber Cipriani unveiled the transformative potential of circulating tumor DNA (ctDNA) testing in cancer diagnostics. This innovative, non-invasive approach not only tracks disease progression and treatment responses but also holds promise for early detection, despite hurdles in sensitivity and interpretation.

1 of 1

Story summary

At the HOPA 2025 Annual Conference in Portland, Oregon, experts Mark Zangardi and Amber Cipriani unveiled the transformative potential of circulating tumor DNA (ctDNA) testing in cancer diagnostics. This innovative, non-invasive approach not only tracks disease progression and treatment responses but also holds promise for early detection, despite hurdles in sensitivity and interpretation.